Investigational Site Number :250005

Nantes 44093

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Asthma, Hematopoietic Neoplasm

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed